Quality Oversight Plans in Pharma: A Comprehensive Guide to Implementation In today’s complex pharmaceutical manufacturing landscape, where outsourcing has become increasingly prevalent, a robust quality oversight plan is essential for ensuring consistent product quality and regulatory compliance. Quality Oversight Meaning
“Supply chain leaders make things work. They get things done, but they don’t shine,” says Knut Alicke, McKinsey Partner and co-author of ‘From Source to Sold‘. ‘From Source to Sold’ contains a series of interviews with top Supply Chain leaders,
WuXi Biologics, a global contract research, development, and manufacturing organisation (CRDMO), has announced a partnership with MediGene to develop TCR-guided T cell engagers (TCR-TCEs) for the treatment of difficult-to-treat tumours. The collaboration, set for three years, aims to design and
The Indian CDMO market is forecast to double over the next five years, as ‘the pharmacy of the world’ becomes increasingly attractive for contract development and manufacturing outsourcing. To understand what is behind this rapid growth, we spoke to Akhil
Phosphorex, a contract development and manufacturing organization (CDMO) specializing in drug delivery, announced today that NOF CORPORATION has completed a strategic investment in the company. This investment, backed by Ampersand Capital Partners, marks a crucial step in Phosphorex’s expansion efforts.
NovAliX, a French preclinical Contract Research Organisation (CRO), has formed a new partnership with Massachusetts-based Bruker Corporation. Announced on 7 August, Bruker has made a minority investment in NovAliX, which will bolster the CRO’s capabilities in biophysics and drug discovery.
Momentum Biotechnologies, a Contract Research Organization (CRO) specialising in mass spectrometry-based drug discovery, has formed a strategic partnership with Cube Biotech, a company known for its expertise in membrane protein targets. The partnership will integrate Cube Biotech’s advanced protein technology
Angiex, a biopharmaceutical company focused on developing innovative therapies for solid cancers, has begun patient dosing for its Phase 1 clinical trial of AGX101, a TM4SF1-directed Antibody-Drug Conjugate (ADC). The trial, which marks the first-in-human study for AGX101, is supported
NEC Bio Therapeutics, a German biotechnology firm based in Mannheim, is collaborating with AGC Biologics to enhance the production of NECVAX-NEO1. This vaccine, designed to be delivered orally, targets patient-specific tumor neoantigens using a bacteria-based DNA platform. It aims to
US Specialty Formulations (USSF) has announced a $15 million expansion of its Lehigh Valley biopharma facility in Allentown, Pennsylvania. The expansion is set to create more than 100 jobs and will enhance the company’s ability to undertake larger projects for
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
